サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1208588

心肺負荷試験システムの世界市場 - 市場規模、シェア、動向分析、機会、予測：製品タイプ、エンドユーザー、地域別（2019年～2029年）

Cardiopulmonary Stress Testing Systems Market- Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Product Type ; By End-user ; By Region
出版日: | 発行: Blueweave Consulting | ページ情報: 英文 200 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
心肺負荷試験システムの世界市場 - 市場規模、シェア、動向分析、機会、予測：製品タイプ、エンドユーザー、地域別（2019年～2029年）
出版日: 2023年01月27日
発行: Blueweave Consulting
ページ情報: 英文 200 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の心肺負荷試験システムの市場規模は、2022年の61億米ドルから、2029年までに89億米ドルに達し、2023年～2029年の間の予測期間中に5.6%の著しいCAGRでの成長が予測されています。

高齢者人口の増加、急性心筋梗塞や狭心症などの冠動脈疾患の有病率上昇などが、世界の心肺負荷試験システムの主要な成長要因です。また、生活習慣病や心臓・肺疾患の罹患率拡大も、心肺負荷試験市場を牽引しています。

当レポートでは、世界の心肺負荷試験システム市場について調査分析し、市場洞察、セグメント別・地域別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 調査の枠組み

第2章 エグゼクティブサマリー

第3章 世界の心肺負荷試験システム市場の洞察

  • 業界バリューチェーン分析
  • DROC分析
    • 促進要因
      • 高齢者人口の増加が市場成長を後押し
      • 心血管疾患の有病率上昇
    • 抑制要因
      • 厳しい規制
      • 開発段階でのより高い課題・多額の試験方法
    • 機会
      • 世界の医療支出の増大
    • 課題
      • COVID-19の影響
  • 技術進歩/最近の開発
  • 規制の枠組み
  • ポーターのファイブフォース分析

第4章 世界の心肺負荷試験システム市場概要

  • 市場規模と予測：金額別（2019年～2029年）
    • 金額別
  • 市場シェアと予測
    • 製品タイプ別
      • ストレス血圧計
      • 運動試験システム
      • ストレス心電図
      • その他
    • エンドユーザー別
      • 病院
      • 専門クリニック
      • 外来手術センター
      • その他
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋（APAC）
      • ラテンアメリカ
      • 中東・アフリカ（MEA）

第5章 北米の心肺負荷試験システム市場

    • 市場規模と予測：金額別（2019年～2029年）
    • 金額別
  • 市場シェアと予測
    • 製品タイプ別
    • エンドユーザー別
    • 国別
      • 米国
      • カナダ

第6章 欧州の心肺負荷試験システム市場

  • 市場規模と予測：金額別（2019年～2029年）
    • 金額別
  • 市場シェアと予測
    • 製品タイプ別
    • エンドユーザー別
    • 国別
      • ドイツ
      • 英国
      • イタリア
      • フランス
      • スペイン
      • オランダ
      • その他欧州

第7章 アジア太平洋の心肺負荷試験システム市場

  • 市場規模と予測：金額別（2019年～2029年）
    • 金額別
  • 市場シェアと予測
    • 製品タイプ別
    • エンドユーザー別
    • 国別
      • 中国
      • インド
      • 日本
      • 韓国
      • オーストラリア・ニュージーランド
      • インドネシア
      • マレーシア
      • シンガポール
      • フィリピン
      • ベトナム
      • その他アジア太平洋

第8章 ラテンアメリカの心肺負荷試験システム市場

  • 市場規模と予測：金額別（2019年～2029年）
    • 金額別
  • 市場シェアと予測
    • 製品タイプ別
    • エンドユーザー別
    • 国別
      • ブラジル
      • メキシコ
      • アルゼンチン
      • ペルー
      • その他ラテンアメリカ

第9章 中東・アフリカの心肺負荷試験システム市場

  • 市場規模と予測：金額別（2019年～2029年）
    • 金額別
  • 市場シェアと予測
    • 製品タイプ別
    • エンドユーザー別
    • 国別
      • サウジアラビア
      • アラブ首長国連邦
      • カタール
      • クウェート
      • 南アフリカ
      • ナイジェリア
      • アルジェリア
      • その他中東・アフリカ

第10章 競合情勢

  • 主要企業・製品一覧
  • 世界の心肺負荷試験システム企業の市場シェア分析（2022年）
  • 競合ベンチマーク：操作パラメータ別
  • 主要な戦略的展開（合併・買収・提携など）

第11章 世界の心肺負荷試験システム市場に対するCOVID-19の影響

第12章 企業プロファイル（会社概要、財務マトリックス、競合情勢、主要な人材、主要な競合、連絡先、戦略的展望、SWOT分析）

  • Thermo Fisher Scientific Ltd.
  • Philips Healthcare
  • Care Medical Ltd.
  • Cosmed Medical and Cardiac Science Corporation
  • GE Healthcare
  • Cardinal Health
  • CareFusion Corporation（BD）
  • Spacelabs Healthcare（OSI Systems, Inc.）
  • MGC Diagnostic Corporation
  • Nihon Kohden Corporation
  • Schiller AG
  • SunTech Medical, Inc.
  • Welch Allyn
  • Hill-Rom Holdings Inc
  • OSI Systems Inc
  • その他

第13章 主要な戦略的推奨事項

第14章 調査手法

目次
Product Code: BWC23073

Global Cardiopulmonary Stress Testing Systems Market Size Expands to Touch USD 8.9 Billion by 2029

Global cardiopulmonary stress testing systems market is flourishing because of an increasing focus on diagnosing rapidly growing prevalence of cardiovascular diseases and geriatric population.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global cardiopulmonary stress testing systems market size at USD 6.1 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global cardiopulmonary stress testing systems market size to grow at a significant CAGR of 5.6% reaching a value of USD 8.9 billion by 2029. Major growth factors of global cardiopulmonary stress testing systems market include growing elder population and rising prevalence of coronary artery disorders such as acute myocardial infarction and angina pectoris. Moreover, rising rates of lifestyle diseases, as well as heart and lung ailments, are driving the cardiopulmonary stress testing market. The cardiopulmonary test assesses and diagnoses heart failure, ischemic heart disease, shortness of breath, and pulmonary problems. As of 2013, cardiovascular diseases were the leading cause of mortality worldwide, which has been a major concern for WHO and numerous healthcare organizations throughout the world and is also projected to drive the cardiopulmonary stress testing devices market during the forecast period. Apart from that, increasing budgetary allocation and the provision of affordable care to patients are on the rise. This has prompted market participants to establish operations new markets and implement technologically advanced testing processes. Therefore, such factors are expected to boost the expansion of the overall market. However, stringent regulations and higher challenges during the development stage and expensive testing procedures are anticipated to restrain the market growth during the period in analysis.

Global Cardiopulmonary Stress Testing Systems Market - Overview

The cardiopulmonary stress test is an evaluation that allows the physician to examine the heart and lungs' function during exercise. The amount of oxygen a person consumes when riding a bike or walking on a treadmill is used to evaluate disorders such as dyspnea, hypertrophic cardiomyopathy, and pulmonary hypertension. The increased prevalence of cardiovascular illnesses and pulmonary ailments is a primary driver of market expansion. One of the primary causes leading to the expansion is an increase in the global prevalence of numerous cardiovascular indications, such as atrial fibrillation, which necessitates the testing of cardiopulmonary function. Furthermore, the increased prevalence of lifestyle diseases, as well as heart and lung disorders, is propelling the cardiopulmonary stress testing market. The cardiopulmonary test evaluates and detects cardiac failures, ischemic heart disease, shortness of breath, and pulmonary issues. The expanding geriatric population is one of the market's primary drivers. According to the United Nations, by 2050, elderly people will make up more than 25% of the population in Europe and North America; 20% in Oceania; 17% in Asia, Latin America, and the Caribbean; and 6% in Africa.

Impact of COVID-19 on Global Cardiopulmonary Stress Testing Systems Market

COVID-19 had a minor impact on the market for cardiopulmonary stress testing systems. It is the most common type of cardiac surgery performed worldwide, and it is a life-saving technique for individuals with serious heart illness and pulmonary disease. Hospitalizations for arrhythmia, heart failure, ischemic heart disease, dyspnea, and heart valve imbalance decreased dramatically as a result of the pandemic. Furthermore, the pandemic is disrupting the medical supply chain, and many enterprises will shift to other geographic zones in the future to assure product availability and supply chain protection. As a result, the COVID-19 pandemic has had an impact on the market. However, the situation is predicted to steadily improve over the forecast period.

Global Cardiopulmonary Stress Testing Systems Market - By Product Type

By product type, global cardiopulmonary stress testing systems market is segmented into Stress Blood Pressure Monitors, Exercise Testing Systems, and Stress ECG. The exercise testing systems segment is expected to hold the highest market share due to its precision and short running duration. Furthermore, the rising choice for these systems by physicians and patients due to their cost-effectiveness and diverse applications contributes to the rise in adoption of these systems, propelling market expansion. However, the stress ECG device segment is establishing its dominance in the global cardiopulmonary stress testing systems market over the projected period due to an increasing senior population with diminishing functional capability. Schiller AG is the global market leader in cardiopulmonary stress testing services. The product pipeline and technology for patient assessment via stress testing at the company have been continuously developed. The CARDIOVIT AT-200 EXCELLENCE ERGOSPIRO is a device that can conveniently and reliably perform both pulmonary function tests (PFTs) and metabolic tests with diagnostic quality-12 or 16-lead exercise ECG.

Competitive Landscape:

Major players operating in global cardiopulmonary stress testing systems market include Thermo Fisher Scientific Ltd., Philips Healthcare, Care Medical Ltd., Cosmed Medical and Cardiac Science Corporation, GE Healthcare, Cardinal Health, CareFusion Corporation (BD), Spacelabs Healthcare (OSI Systems, Inc.), MGC Diagnostic Corporation, Nihon Kohden Corporation, Schiller AG, SunTech Medical, Inc., Welch Allyn, Hill-Rom Holdings Inc, and OSI Systems Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Cardiopulmonary Stress Testing Systems Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Cardiopulmonary Stress Testing Systems Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Cardiopulmonary Stress Testing Systems Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Rise in Geriatric Population Boost Market Growth
      • 3.2.1.2. Rising Prevalence of Cardiovascular Diseases
    • 3.2.2. Restraints
      • 3.2.2.1. Stringent Regulations
      • 3.2.2.2. Higher Challenges During the Development Stage and Expensive Testing Procedures
    • 3.2.3. Opportunities
      • 3.2.3.1. Rise in Global Healthcare Expenditure
    • 3.2.4. Challenges
      • 3.2.4.1. Impact of COVID-19
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Cardiopulmonary Stress Testing Systems Market Overview

  • 4.1. Market Size & Forecast, by Value, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Product Type
      • 4.2.1.1. Stress Blood Pressure Monitors
      • 4.2.1.2. Exercise Testing Systems
      • 4.2.1.3. Stress ECG
      • 4.2.1.4. Others
    • 4.2.2. By End-user
      • 4.2.2.1. Hospitals
      • 4.2.2.2. Specialty Clinics
      • 4.2.2.3. Ambulatory Surgical Centers
      • 4.2.2.4. Others
    • 4.2.3. By Region
      • 4.2.3.1. North America
      • 4.2.3.2. Europe
      • 4.2.3.3. Asia Pacific (APAC)
      • 4.2.3.4. Latin America
      • 4.2.3.5. Middle East and Africa (MEA)

5. North America Cardiopulmonary Stress Testing Systems Market

    • 5.1.1. Market Size & Forecast, by Value, 2019-2029
    • 5.1.2. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type
    • 5.2.2. By End-user
    • 5.2.3. By Country
      • 5.2.3.1. US
      • 5.2.3.1.1. By Product Type
      • 5.2.3.1.2. By End-user
      • 5.2.3.2. Canada
      • 5.2.3.2.1. By Product Type
      • 5.2.3.2.2. By End-user

6. Europe Cardiopulmonary Stress Testing Systems Market

  • 6.1. Market Size & Forecast, by Value, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By End-user
    • 6.2.3. By Country
      • 6.2.3.1. Germany
      • 6.2.3.1.1. By Product Type
      • 6.2.3.1.2. By End-user
      • 6.2.3.2. United Kingdom
      • 6.2.3.2.1. By Product Type
      • 6.2.3.2.2. By End-user
      • 6.2.3.3. Italy
      • 6.2.3.3.1. By Product Type
      • 6.2.3.3.2. By End-user
      • 6.2.3.4. France
      • 6.2.3.4.1. By Product Type
      • 6.2.3.4.2. By End-user
      • 6.2.3.5. Spain
      • 6.2.3.5.1. By Product Type
      • 6.2.3.5.2. By End-user
      • 6.2.3.6. The Netherlands
      • 6.2.3.6.1. By Product Type
      • 6.2.3.6.2. By End-user
      • 6.2.3.7. Rest of Europe
      • 6.2.3.7.1. By Product Type
      • 6.2.3.7.2. By End-user

7. Asia Pacific Cardiopulmonary Stress Testing Systems Market

  • 7.1. Market Size & Forecast, by Value, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By End-user
    • 7.2.3. By Country
      • 7.2.3.1. China
      • 7.2.3.1.1. By Product Type
      • 7.2.3.1.2. By End-user
      • 7.2.3.2. India
      • 7.2.3.2.1. By Product Type
      • 7.2.3.2.2. By End-user
      • 7.2.3.3. Japan
      • 7.2.3.3.1. By Product Type
      • 7.2.3.3.2. By End-user
      • 7.2.3.4. South Korea
      • 7.2.3.4.1. By Product Type
      • 7.2.3.4.2. By End-user
      • 7.2.3.5. Australia & New Zealand
      • 7.2.3.5.1. By Product Type
      • 7.2.3.5.2. By End-user
      • 7.2.3.6. Indonesia
      • 7.2.3.6.1. By Product Type
      • 7.2.3.6.2. By End-user
      • 7.2.3.7. Malaysia
      • 7.2.3.7.1. By Product Type
      • 7.2.3.7.2. By End-user
      • 7.2.3.8. Singapore
      • 7.2.3.8.1. By Product Type
      • 7.2.3.8.2. By End-user
      • 7.2.3.9. Philippines
      • 7.2.3.9.1. By Product Type
      • 7.2.3.9.2. By End-user
      • 7.2.3.10. Vietnam
      • 7.2.3.10.1. By Product Type
      • 7.2.3.10.2. By End-user
      • 7.2.3.11. Rest of Asia Pacific
      • 7.2.3.11.1. By Product Type
      • 7.2.3.11.2. By End-user

8. Latin America Cardiopulmonary Stress Testing Systems Market

  • 8.1. Market Size & Forecast, by Value, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By End-user
    • 8.2.3. By Country
      • 8.2.3.1. Brazil
      • 8.2.3.1.1. By Product Type
      • 8.2.3.1.2. By End-user
      • 8.2.3.2. Mexico
      • 8.2.3.2.1. By Product Type
      • 8.2.3.2.2. By End-user
      • 8.2.3.3. Argentina
      • 8.2.3.3.1. By Product Type
      • 8.2.3.3.2. By End-user
      • 8.2.3.3.3. By Drive Type
      • 8.2.3.4. Peru
      • 8.2.3.4.1. By Product Type
      • 8.2.3.4.2. By End-user
      • 8.2.3.5. Rest of Latin America
      • 8.2.3.5.1. By Product Type
      • 8.2.3.5.2. By End-user

9. Middle East & Africa Cardiopulmonary Stress Testing Systems Market

  • 9.1. Market Size & Forecast, by Value, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By End-user
    • 9.2.3. By Country
      • 9.2.3.1. Saudi Arabia
      • 9.2.3.1.1. By Product Type
      • 9.2.3.1.2. By End-user
      • 9.2.3.2. UAE
      • 9.2.3.2.1. By Product Type
      • 9.2.3.2.2. By End-user
      • 9.2.3.3. Qatar
      • 9.2.3.3.1. By Product Type
      • 9.2.3.3.2. By End-user
      • 9.2.3.4. Kuwait
      • 9.2.3.4.1. By Product Type
      • 9.2.3.4.2. By End-user
      • 9.2.3.5. South Africa
      • 9.2.3.5.1. By Product Type
      • 9.2.3.5.2. By End-user
      • 9.2.3.6. Nigeria
      • 9.2.3.6.1. By Product Type
      • 9.2.3.6.2. By End-user
      • 9.2.3.7. Algeria
      • 9.2.3.7.1. By Product Type
      • 9.2.3.7.2. By End-user
      • 9.2.3.8. Rest of Middle East & Africa
      • 9.2.3.8.1. By Product Type
      • 9.2.3.8.2. By End-user

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Cardiopulmonary Stress Testing Systems Company Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)

11. Impact of Covid-19 on Global Cardiopulmonary Stress Testing Systems Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Thermo Fisher Scientific Ltd.
  • 12.2. Philips Healthcare
  • 12.3. Care Medical Ltd.
  • 12.4. Cosmed Medical and Cardiac Science Corporation
  • 12.5. GE Healthcare
  • 12.6. Cardinal Health
  • 12.7. CareFusion Corporation (BD)
  • 12.8. Spacelabs Healthcare (OSI Systems, Inc.)
  • 12.9. MGC Diagnostic Corporation
  • 12.10. Nihon Kohden Corporation
  • 12.11. Schiller AG
  • 12.12. SunTech Medical, Inc.
  • 12.13. Welch Allyn
  • 12.14. Hill-Rom Holdings Inc
  • 12.15. OSI Systems Inc
  • 12.16. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations